Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
暂无分享,去创建一个
Amy Y. Chen | E. Ward | A. Stewart | M. Halpern | M. Leitch | N. Schrag
[1] A. Y. de Kanter,et al. 5-Year follow-up of sentinel node negative breast cancer patients. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] P. Schlag,et al. Long‐term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection , 2006, Journal of surgical oncology.
[3] C. Laronga,et al. Impact of Race on Breast Cancer in Lower Socioeconomic Status Women , 2006, The breast journal.
[4] K. McMasters,et al. Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. , 2005, American journal of surgery.
[5] J. Hentz,et al. Older Age Independently Predicts a Lower Risk of Sentinel Lymph Node Metastasis in Breast Cancer , 2005, Annals of Surgical Oncology.
[6] E. Winer,et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Giuliano,et al. Sentinel Node Skills Verification and Surgeon Performance: Data From a Multicenter Clinical Trial for Early-Stage Breast Cancer , 2005, Annals of surgery.
[8] J. Gardiner,et al. Cancer, Medicaid enrollment, and survival disparities , 2005, Cancer.
[9] R. Coates,et al. Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma , 2004, Cancer.
[10] P. Dijkstra,et al. Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer , 2004, Annals of Surgical Oncology.
[11] P. F. Short,et al. Battery-powered health insurance? Stability in coverage of the uninsured. , 2003, Health affairs.
[12] Rebecca Ottesen,et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. , 2003, Journal of the National Cancer Institute.
[13] C. Bradley,et al. Late Stage Cancers in a Medicaid-insured Population , 2003, Medical care.
[14] J. Donohue,et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. , 2003, Archives of surgery.
[15] S. Edge,et al. Patient and provider characteristics that affect the use of axillary dissection in older women with Stage I–II breast carcinoma , 2002, Cancer.
[16] J. Heimbach,et al. Breast conservation therapy in affiliated county, university, and private hospitals. , 1999, American journal of surgery.
[17] J. Zhang,et al. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.
[18] C. McNeil. Sentinel node biopsy: studies should bring needed data. , 1998, Journal of the National Cancer Institute.
[19] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[20] C. Ko,et al. Beyond the Clinical Trials: How Often Is Sentinel Lymph Node Dissection Performed for Breast Cancer? , 2004, Annals of Surgical Oncology.
[21] M. Walker,et al. Patterns of Recurrence After Sentinel Lymph Node Biopsy for Breast Cancer , 2003, Annals of Surgical Oncology.
[22] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.